ZA894984B - Antiviral method for human immunodeficiency virus with bu-3608 - Google Patents

Antiviral method for human immunodeficiency virus with bu-3608

Info

Publication number
ZA894984B
ZA894984B ZA894984A ZA894984A ZA894984B ZA 894984 B ZA894984 B ZA 894984B ZA 894984 A ZA894984 A ZA 894984A ZA 894984 A ZA894984 A ZA 894984A ZA 894984 B ZA894984 B ZA 894984B
Authority
ZA
South Africa
Prior art keywords
human immunodeficiency
immunodeficiency virus
susceptible
hiv
aids
Prior art date
Application number
ZA894984A
Other languages
English (en)
Inventor
Toshikazu Oki
Oki Toshikazu
Noaki Yamamoto
Yamamoto Noaki
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ZA894984B publication Critical patent/ZA894984B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/244—Anthraquinone radicals, e.g. sennosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA894984A 1988-07-01 1989-06-30 Antiviral method for human immunodeficiency virus with bu-3608 ZA894984B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21422688A 1988-07-01 1988-07-01

Publications (1)

Publication Number Publication Date
ZA894984B true ZA894984B (en) 1990-03-28

Family

ID=22798273

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA894984A ZA894984B (en) 1988-07-01 1989-06-30 Antiviral method for human immunodeficiency virus with bu-3608

Country Status (12)

Country Link
EP (1) EP0351625B1 (de)
JP (1) JP2802336B2 (de)
KR (1) KR0131323B1 (de)
AT (1) ATE87827T1 (de)
CA (1) CA1335078C (de)
CY (1) CY1847A (de)
DE (1) DE68905875T2 (de)
ES (1) ES2054935T3 (de)
GR (1) GR3007580T3 (de)
HK (1) HK110095A (de)
IL (1) IL90783A (de)
ZA (1) ZA894984B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338728A (en) * 1992-08-14 1994-08-16 Bristol-Myers Squibb Pradimicin compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870165A (en) * 1987-02-02 1989-09-26 Bristol-Myers Company Antifungal antibiotics

Also Published As

Publication number Publication date
KR0131323B1 (ko) 1998-04-17
DE68905875T2 (de) 1993-07-15
DE68905875D1 (de) 1993-05-13
JP2802336B2 (ja) 1998-09-24
JPH0248530A (ja) 1990-02-19
EP0351625A1 (de) 1990-01-24
ATE87827T1 (de) 1993-04-15
IL90783A (en) 1994-01-25
CY1847A (en) 1996-03-08
EP0351625B1 (de) 1993-04-07
IL90783A0 (en) 1990-01-18
HK110095A (en) 1995-07-14
KR900001374A (ko) 1990-02-27
CA1335078C (en) 1995-04-04
ES2054935T3 (es) 1994-08-16
GR3007580T3 (de) 1993-08-31

Similar Documents

Publication Publication Date Title
ZA907338B (en) Thienylcarboxylates of amino alcohols
DK92788A (da) Anvendelse af 3'-deoxy-3'-flourguanosider til fremstilling af laegemidler mod retrovira
IE873245L (en) Administering a deoxythymidine
AU8448091A (en) Novel polypeptide and anti-hiv drug prepared therefrom
AU2930889A (en) Pharmaceutical preparation for treating immunodeficiency conditions
EP0323157A3 (de) Antivirale Verbindungen und Methoden
WO1990013281A3 (en) Method of suppressing hiv infection
ZA894984B (en) Antiviral method for human immunodeficiency virus with bu-3608
AU2833789A (en) Non-reverting rna viruses
GR3014952T3 (en) Use of an immunoglobulin-containing composition in the prophylaxis and therapy of AIDS of human.
EP0255242A3 (de) Oncornavirusimpfstoffe
AU7514087A (en) Vaccine containing the protein f of the aids virus
EP0311108A3 (de) Anti-HIV-aktive 3'-Azido-2,6-diaminopurine-2',3'-dideoxyriboside
EP0316592A3 (de) 3'-Fluor-2',3'-dideoxyuridin und seine therapeutische Verwendung
FI881123A7 (fi) Human Immunodeficiency Viruksen (HIV) inaktivoiminen proteiinipitoisissa liuoksissa fenolilla.
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
FI891917A7 (fi) HIV:n rekombinantti-GAG-prekursori, tuote, menetelmä ja käyttö AIDS-rokotteena
ZA896230B (en) Pharmaceutical composition for inhibiting infection with virus causative of acquired human immunodefeciency syndrome
UA6149A1 (uk) 2-(2'7'-діацетоксіфлуореніліден-9'-гідразоно)-5-(п-нітробензіліден)-тіазолідон-4,що виявляє противірусну дію щодо віруса грипу а та а-2, а також віруса осповакцини
WO1988008707A3 (en) Rubradirin derivatives for treatment of hiv infection
AU3713489A (en) Non-reverting rna viruses
LV10497A (lv) Panemiens vakcinas iegusanai kas satur no HIV-1 virusa apvalka gena atvasinatus polipeptidus
UA6146A1 (uk) 1,1-біс-[2-(2,7-діацетоксифлуорениліден-9-гідразоно)тиазолідон-4-іл-5]-о-нітрофенилметан, що виявляє антивірусну дію відносно рнк- та днк- вмістних вірусів
UA7930A1 (uk) 2-(2,7-діацетоксіфлуорениліден-9-гідразоно)-5-фурфурилідентіазолідон-4, що виявляє противірусну дію відносно віруса венесуельського енцефаліту коней та віруса грипа типу а та а-2
SU1797350A1 (ru) Способ обнаружения вируса иммунодефицита человека